BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Press Releases

  ANI Pharmaceuticals to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference

  March 31, 2025

   · 

  1 min read
• Press Releases

  Geron Plans to Announce First Quarter 2025 Financial Results on May 7, 2025

  March 31, 2025

   · 

  1 min read
• Press Releases

  Travere Therapeutics to Present New FILSPARI® (sparsentan) Data at the National Kidney Foundation Spring Clinical Meetings 2025

  March 31, 2025

   · 

  15 min read
• Press Releases

  Neural Therapeutics Commences Trading on Frankfurt Stock Exchange

  March 31, 2025

   · 

  5 min read
• Press Releases

  Envoy Medical Reports Fourth Quarter and Full Year 2024 Financial Results

  Company Provides Corporate Update that Includes Information on its Progress Enrolling Subjects in its Pivotal Clinical Study for Breakthrough Device, the Fully Implanted Acclaim® Cochlear Implant

  March 31, 2025

   · 

  15 min read
• Press Releases

  WINREVAIR™ (sotatercept-csrk) Reduced the Risk of a Composite of All-Cause Death, Lung Transplantation and Hospitalization for Pulmonary Arterial Hypertension (PAH) by 76% Compared to Placebo in the Phase 3 ZENITH Trial

  March 31, 2025

   · 

  12 min read
• Press Releases

  eyonis™ LCS, Median Technologies’ AI-Powered Software as a Medical Device for Lung Cancer Screening, Confirmed Efficacy and Safety in RELIVE Pivotal Study

  March 31, 2025

   · 

  8 min read
• Press Releases

  Transcend Therapeutics Announces Primary Endpoint Met in IMPACT-1 Phase 2 Study of TSND-201 in PTSD

  March 31, 2025

   · 

  1 min read
• Press Releases

  BioCardia’s Conference Call Today, Monday, March 31, 2025 to be Held at 4:30PM EDT Time Today

  March 31, 2025

   · 

  1 min read
• Press Releases

  Hoth Therapeutics Receives USPTO Filing Receipt for HT-001 Formulation Patent Application, Expanding Existing Patent Coverage

  March 31, 2025

   · 

  4 min read